IQVIA

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn mo...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CH
  • 2018
    On CPHI since
View company profile
Contact info
  • Website
  • Dorfplatz 4, 6330, Cham, Switzerland
Show contact info Hide contact info

Products from IQVIA (3)

  • Managed Markets Data & Analytic Solutions

    Product Managed Markets Data & Analytic Solutions

    Fundamental to the success of your market access strategy is clear visibility into payer, provider and patient behavior. IQVIA’s comprehensive real-world database includes lifecycle transactions, which offer the critical level of detail required to untangle the complex interaction of payer utilization ...
  • Brand and Promotional Analysis

    Product Brand and Promotional Analysis

    Powered by the IQVIA CORE™, our promotional analysis can help you understand the trajectory of your brand and measure its progress along the way. We can help you see where you are today, where you’re going and help you make adjustments as part of your path forward. Find out what you need to know a...
  • Launch Performance by Patient Segment

    Product Launch Performance by Patient Segment

    Each launch has a million moving pieces. Almost all are based on what you know about your market. Which patients are using which products? What is their patient journey? What types of physicians prescribe them? How do treatments and costs vary by geography or provider? Primary market research provides ...

IQVIA Resources (1)

  • Cost and volume pressures giving rise to value-added medicines: IQVIA

    News Cost and volume pressures giving rise to value-added medicines: IQVIA

    Rising pharmaceutical cost pressures and volume growth deceleration are forcing pharmaceutical companies to attempt to extract further value from existing medicines rather than solely pursuing new molecules, according to Aurelio Arias, Engagement Manager, European Thought Leadership, IQVIA.
    10 Feb 2020